Các Vấn Đề Nổi Bật Trong Viêm Dạ Dày Tự Miễn

Toh BH, van Driel IR, Gleeson PA (1997) Pernicious anemia. N Engl J Med 337(20):1441–1448 Field J, Biondo MA, Murphy K, Alderuccio F, Toh BH (2005) Experimental autoimmune gastritis: mouse models of human organ-specific autoimmune disease. Int Rev Immunol 24(1–2):93–110 Alderuccio F, Sentry JW, Marshall AC, Biondo M, Toh BH (2002) Animal models of human disease: experimental autoimmune gastritis—a model for autoimmune gastritis and pernicious anemia. Clin Immunol 102(1):48–58 Biondo M, Nasa Z, Marshall A, Toh BH, Alderuccio F (2001) Local transgenic expression of granulocyte macrophage-colony stimulating factor initiates autoimmunity. J Immunol 166(3):2090–2099 Toh BH, Sentry JW, Alderuccio F (2000) The causative H+/K + ATPase antigen in the pathogenesis of autoimmune gastritis. Immunol Today 21(7):348–354 Bergman MP, Amedei A, D'Elios MM, Azzurri A, Benagiano M, Tamburini C, van der Zee R, Vandenbroucke-Grauls CM, Appelmelk BJ, Del Prete G (2003) Characterization of H+, K + −ATPase T cell epitopes in human autoimmune gastritis. Eur J Immunol 33(2):539–545 Adamu MA, Weck MN, Gao L, Brenner H (2010) Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol 25(7):439–448 Lombardo L, Leto R, Molinaro G, Migliardi M, Ravarino N, Rocca R, Torchio B (2010) Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med (in press) Telaranta-Keerie A, Kara R, Paloheimo L, Härkönen M, Sipponen P (2010) Prevalence ofundiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints. Scand J Gastroenterol (in press) Ang DK, Brodnicki TC, Jordan MA, Wilson WE, Silveira P, Gliddon BL, Baxter AG, van Driel IR (2007) Two genetic loci independently confer susceptibility to autoimmune gastritis. Int Immunol 19(9):1135–1144 Lahner E, Spoletini M, Buzzetti R, Corleto VD, Vannella L, Petrone A, Annibale B (2010) HLA-DRB1*03 and DRB1*04 are associated with atrophic gastritis in an Italian population. Dig Liver Dis (in press) Oksanen AM, Haimila KE, Rautelin HI, Partanen JA (2010) Immunogenetic characteristics of patients with autoimmune gastritis. World J Gastroenterol 16(3):354–358 Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, van der Zee R, Telford JL, Vandenbroucke-Grauls CM, D’Elios MM, Del Prete G (2003) Molecular mimicry between Helicobacter pylori antigens and H+, K + –adenosine triphosphatase in human gastric autoimmunity. J Exp Med 198(8):1147–1156 Bergman MP, Vandenbroucke-Grauls CM, Appelmelk BJ, D’Elios MM, Amedei A, Azzurri A, Benagiano M, Del Prete G (2005) The story so far: helicobacter pylori and gastric autoimmunity. Int Rev Immunol 24(1–2):63–91 Veijola LI, Oksanen AM, Sipponen PI, Rautelin HI (2010) Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol 16(1):83–88 Gao L, Weck MN, Nieters A, Brenner H (2009) Inverse association between a pro-inflammatory genetic profile and Helicobacter pylori seropositivity among patients with chronic atrophic gastritis: enhanced elimination of the infection during disease progression? Eur J Cancer 45(16):2860–2866 Weck MN, Gao L, Brenner H (2009) Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease. Epidemiology 20(4):569–574 Alderuccio F, Toh BH, Tan SS, Gleeson PA, van Driel IR (1993) An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus. J Exp Med 178(2):419–426 Klein L, Kyewski B (2000) “Promiscuous” expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity? J Mol Med 78(9):483–494, Review Gardner JM, Devoss JJ, Friedman RS, Wong DJ, Tan YX, Zhou X, Johannes KP, Su MA, Chang HY, Krummel MF, Anderson MS (2008) Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321(5890):843–847 Gotter J, Brors B, Hergenhahn M, Kyewski B (2004) Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J Exp Med 199(2):155–166 Macedo C, Evangelista AF, Magalhães DA, Fornari TA, Linhares LL, Junta CM, Silva GL, Sakamoto-Hojo ET, Donadi EA, Savino W, Passos GA (2009) Evidence for a network transcriptional control of promiscuous gene expression in medullary thymic epithelial cells. Mol Immunol 46(16):3240–3244 Irla M, Hollander G, Reith W (2010) Control of central self-tolerance induction by autoreactive CD4+ thymocytes. Trends Immunol 31(2):71–79 Alderuccio F, Gleeson PA, Berzins SP, Martin M, Van Driel IR, Toh BH (1997) Expression of the gastric H/K-ATPase alpha-subunit in the thymus may explain the dominant role of the beta-subunit in the pathogenesis of autoimmune gastritis. Autoimmunity 25(3):167–175 Read S, Hogan TV, Zwar TD, Gleeson PA, van Driel IR (2007) Prevention of autoimmune gastritis in mice requires extra-thymic T-cell deletion and suppression by regulatory T cells. Gastroenterology 133(2):547–558 Fukuma K, Sakaguchi S, Kuribayashi K, Chen WL, Morishita R, Sekita K, Uchino H, Masuda T (1988) Immunologic and clinical studies on murine experimental autoimmune gastritis induced by neonatal thymectomy. Gastroenterology 94(2):274–283 Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T (1985) Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 161(1):72–87 Suri-Payer E, Amar AZ, Thornton AM, Shevach EM (1998) CD4 + CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160(3):1212–1218 DiPaolo RJ, Glass DD, Bijwaard KE, Shevach EM (2005) CD4 + CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. J Immunol 175(11):7135–7142 DiPaolo RJ, Brinster C, Davidson TS, Andersson J, Glass D, Shevach EM (2007) Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol 179(7):4685–4693 Huter EN, Stummvoll GH, DiPaolo RJ, Glass DD, Shevach EM (2009) Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis: Ag-specific regulatory T cells are more potent suppressors than polyclonal regulatory T cells. Int Immunopharmacol 9(5):540–545 Andersson J, Tran DQ, Pesu M, Davidson TS, Ramsey H, O’Shea JJ, Shevach EM (2008) CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med 205(9):1975–1981 Scheinecker C, McHugh R, Shevach EM, Germain RN (2002) Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med 196(8):1079–1090 Barrett SP, Riordon A, Toh BH, Gleeson PA, van Driel IR (2000) Homing and adhesion molecules in autoimmune gastritis. J Leukoc Biol 67(2):169–173 Suri-Payer E, Amar AZ, McHugh R, Natarajan K, Margulies DH, Shevach EM (1999) Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur J Immunol 29(2):669–677 McHugh RS, Shevach EM, Margulies DH, Natarajan K (2001) A T cell receptor transgenic model of severe, spontaneous organ-specific autoimmunity. Eur J Immunol 31(7):2094–2103 Candon S, McHugh RS, Foucras G, Natarajan K, Shevach EM, Margulies DH (2004) Spontaneous organ-specific Th2-mediated autoimmunity in TCR transgenic mice. J Immunol 172(5):2917–2924 Stummvoll GH, DiPaolo RJ, Huter EN, Davidson TS, Glass D, Ward JM, Shevach EM (2008) Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J Immunol 181(3):1908–1916 Lam-Tse WK, Batstra MR, Koeleman BP, Roep BO, Bruining MG, Aanstoot HJ, Drexhage HA (2003) The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes. Pediatr Endocrinol Rev 1(1):22–37 Tsirogianni A, Pipi E, Soufleros K (2009) Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus. Autoimmun Rev 8(8):687–691 Lahner E, Centanni M, Agnello G, Gargano L, Vannella L, Iannoni C, Delle Fave G, Annibale B (2008) Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med 121(2):136–141 Ness-Abramof R, Nabriski DA, Braverman LE, Shilo L, Weiss E, Reshef T, Shapiro MS, Shenkman L (2006) Prevalence and evaluation of B12 deficiency in patients with autoimmune thyroid disease. Am J Med Sci 332(3):119–122 Burman P, Kämpe O, Kraaz W, Lööf L, Smolka A, Karlsson A, Karlsson-Parra A (1992) A study of autoimmune gastritis in the postpartum period and at a 5-year follow-up. Gastroenterology 103(3):934–942 Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J (2006) Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood 107(4):1673–1679 Hershko C, Patz J, Ronson A (2007) The anemia of achylia gastrica revisited. Blood Cells Mol Dis 39(2):178–183 Zauli D, Tosti A, Biasco G, Miserocchi F, Patrizi A, Azzaroni D, Andriani G, Di Febo G, Callegari C (1986) Prevalence of autoimmune atrophic gastritis in vitiligo. Digestion 34(3):169–172 De Block CE, De Leeuw IH, Van Gaal LF (2008) Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab 93(2):363–371 Korstanje A, den Hartog G, Biemond I, Lamers CB (2002) The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol (236):22–26. Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa T (2009) Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 15(7):853–859 Korstanje A, van Eeden S, Offerhaus JA, Waltman FL, Hartog G, Roelandse FW, Souverijn JH, Biemond I, Lamers CB (2008) Comparison between serology and histology in the diagnosis of advanced gastric body atrophy: a study in a Dutch primary community. J Clin Gastroenterol 42(1):18–22 Checchi S, Montanaro A, Pasqui L, Ciuoli C, Cevenini G, Sestini F, Fioravanti C, Pacini F (2007) Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 92(11):4346–4351 Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T (2004) Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio—a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 51(59):1249–1254 Kawashima J, Ohno S, Sakurada T, Takabayashi H, Kudo M, Ro S, Kato S, Yakabi K (2009) Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol 44(10):1046–1054 Chuang JS, Callaghan JM, Gleeson PA, Toh BH (1992) Diagnostic ELISA for parietal cell autoantibody using tomato lectin-purified gastric H+/K(+)-ATPase (proton pump). Autoimmunity 12(1):1–7 Sugiu K, Kamada T, Ito M, Kaya S, Tanaka A, Kusunoki H, Hata J, Haruma K (2006) Evaluation of an ELISA for detection of anti-parietal cell antibody. Hepatogastroenterology 53(67):11–14 Lahner E, Norman GL, Severi C, Encabo S, Shums Z, Vannella L, Delle Fave G, Annibale B (2009) Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol 104(8):2071–2079 Khan S, Del-Duca C, Fenton E, Holding S, Hirst J, Doré PC, Sewell WA (2009) Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia. J Clin Pathol 62(5):439–441 Tozzoli R, Kodermaz G, Perosa AR, Tampoia M, Zucano A, Antico A, Bizzaro N (2010) Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev (in press) Alonso N, Granada ML, Soldevila B, Salinas I, Joaquin C, Reverter JL, Juncà J, Martínez Cáceres EM, Sanmartí A (2010) Serum autoimmune gastritis markers, pepsinogen 1 and parietal cell antibodies in patients with type 1 diabetes mellitus. A 5 year prospective study. J Endocrinol Invest (in press) Biondo M, Field J, Toh BH, Alderuccio F (2006) Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis. J Pathol 209(3):384–391 Marmont AM (2008) Will hematopoietic stem cell transplantation cure human autoimmune diseases? J Autoimmun 30(3):145–150 French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A, Georgiou HM, Kay TW, Harrison LC, Lew AM (1997) Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46(1):34–39, Erratum in: Diabetes 1997 May;46(5):924 Chan J, Ban EJ, Chun KH, Wang S, Bäckström BT, Bernard CC, Toh BH, Alderuccio F (2008) Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J Immunol 181(11):7571–7580 Xu B, Haviernik P, Wolfraim LA, Bunting KD, Scott DW (2006) Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. Mol Ther 13(1):42–48 Alderuccio F, Chan J, Ko HJ, Chung JY, Nasa Z, Toh BH (2010) A molecular Trojan horse: hijacking the bone marrow to treat autoimmune diseases. Discov Med 49:512–518, PubMed PMID: 20587340 Alderuccio F, Chan J, Scott DW, Toh BH (2009) Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease. Trends Mol Med 15(8):344–351